Free Trial

China SXT Pharmaceuticals (SXTC) Short Interest Ratio & Short Volume

China SXT Pharmaceuticals logo
$0.32 -0.02 (-5.91%)
(As of 12/20/2024 05:31 PM ET)

China SXT Pharmaceuticals Short Interest Data

China SXT Pharmaceuticals (SXTC) has a short interest of 72,100 shares, representing 2.10% of the float (the number of shares available for trading by the public). This marks a 7.61% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 805,195 shares to cover all short positions.

Current Short Interest
72,100 shares
Previous Short Interest
67,000 shares
Change Vs. Previous Month
+7.61%
Dollar Volume Sold Short
$28,840.00
Short Interest Ratio
0.1 Days to Cover
Last Record Date
November 30, 2024
Outstanding Shares
4,062,000 shares
Float Size
3,430,000 shares
Short Percent of Float
2.10%
Today's Trading Volume
648,493 shares
Average Trading Volume
805,195 shares
Today's Volume Vs. Average
81%
Short Selling China SXT Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SXTC Short Interest Over Time

SXTC Days to Cover Over Time

SXTC Percentage of Float Shorted Over Time

China SXT Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/202472,100 shares $28,840.00 +7.6%2.1%0.1 $0.40
11/15/202467,000 shares $25,935.03 -36.4%2.0%0.1 $0.39
10/31/2024105,300 shares $58,862.70 -46.3%3.1%0.2 $0.56
10/15/2024196,000 shares $123,970.00 -22.1%5.7%0.3 $0.63
9/30/2024251,600 shares $183,617.68 -44.7%7.3%0.3 $0.73
9/15/2024455,300 shares $303,229.80 +744.7%13.1%0.7 $0.67
8/31/202453,900 shares $33,886.93 +32.8%1.6%0.1 $0.63
8/15/202440,600 shares $41,818.00 -23.3%1.2%0.1 $1.03
7/31/202452,900 shares $58,719.00 -68.2%7.6%0.1 $1.11
7/15/2024166,100 shares $195,998.00 +347.7%24.0%0.3 $1.18
6/30/202437,100 shares $40,439.00 -25.1%5.4%0 $1.09
6/15/202449,500 shares $54,450.00 +43.1%9.3%0 $1.10
5/31/202434,600 shares $36,343.84 +76.5%6.5%0 $1.05
5/15/202419,600 shares $21,364.00 +36.1%3.6%0 $1.09
4/30/202414,400 shares $15,264.00 -77.4%2.6%0 $1.06
4/15/202463,600 shares $74,412.00 +142.8%11.6%0.1 $1.17
3/31/202426,200 shares $44,016.00 +376.4%4.8%0 $1.68
3/15/20245,500 shares $9,570.00 -93.4%1.0%0 $1.74
2/29/202482,800 shares $163,116.00 +145.0%15.1%0.1 $1.97
2/15/202433,800 shares $73,684.00 -59.3%6.2%0 $2.18
1/31/202483,000 shares $161,020.00 +538.5%14.8%0.1 $1.94
1/15/202413,000 shares $24,440.00 +100.0%2.3%0 $1.88
12/31/20236,500 shares $25,805.00 -67.3%1.2%0 $3.97
12/15/202319,900 shares $38,805.00 -33.7%3.6%0.1 $1.95
11/30/202330,000 shares $63,600.00 +67.6%5.3%0.2 $2.12
11/15/202317,900 shares $42,602.00 -70.2%3.2%0.1 $2.38
10/31/202360,100 shares $129,221.01 -21.4%10.7%0.3 $2.15
10/15/202376,500 shares $225,675.00 +948.0%13.6%0.3 $2.95
9/30/20237,300 shares $22,447.50 -98.7%0.1%0 $3.08
9/15/2023575,400 shares $75,780.18 +99.7%4.6%0.1 $0.13
8/31/2023288,100 shares $32,555.30 +553.3%2.4%0.1 $0.11
8/15/202344,100 shares $6,513.57 -61.1%0.4%0 $0.15
7/31/2023113,300 shares $23,113.20 +18.1%1.0%0.2 $0.20
7/15/202395,900 shares $18,796.40 -8.2%1.1%0.1 $0.20
6/30/2023104,500 shares $24,557.50 +5.9%1.2%0.1 $0.24
6/15/202398,700 shares $23,737.35 +4.0%1.2%0.1 $0.24
5/31/202394,900 shares $19,255.21 -69.1%1.1%0.2 $0.20
5/15/2023307,300 shares $69,019.27 +1,034.0%3.6%0.5 $0.22
4/30/202327,100 shares $6,720.80 +942.3%0.3%0 $0.25
4/15/20232,600 shares $621.14 -83.5%0.1%0 $0.24
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
3/31/202315,800 shares $4,480.88 +13.7%0.5%0 $0.28
3/15/202313,900 shares $4,075.48 -68.3%0.5%0 $0.29
2/28/202343,800 shares $17,182.74 -25.5%1.4%0.1 $0.39
2/15/202358,800 shares $28,812.00 -18.0%1.8%0.1 $0.49
1/31/202371,700 shares $40,144.83 -10.7%2.3%0.1 $0.56
1/15/202380,300 shares $47,377.00 -22.8%1.7%0.1 $0.59
12/30/2022104,000 shares $56,368.00 -68.0%2.2%0.2 $0.54
12/15/2022324,500 shares $195,803.30 +587.5%7.6%0.6 $0.60
11/30/202247,200 shares $33,035.28 +193.2%2.2%0.1 $0.70
11/15/202216,100 shares $10,787.00 -17.0%0.7%0 $0.67
10/31/202219,400 shares $11,640.00 -62.4%0.9%0 $0.60
10/15/202251,600 shares $35,088.00 -16.9%2.4%0.1 $0.68
9/30/202262,100 shares $47,817.00 -50.2%2.8%0.1 $0.77
9/15/2022124,600 shares $139,552.00 -11.3%5.7%0.3 $1.12
8/31/2022140,400 shares $197,262.00 +345.7%6.4%0.3 $1.41
8/15/202231,500 shares $51,345.00 +34.6%1.3%0.2 $1.63
7/31/202223,400 shares $34,164.00 -67.1%1.0%0.2 $1.46
7/15/202271,100 shares $129,402.00 +17.5%4.1%0.7 $1.82
6/30/202260,500 shares $105,875.00 -38.3%3.5%0.6 $1.75
6/15/202298,100 shares $162,846.00 +42.4%5.6%0.3 $1.66
5/31/202268,900 shares $144,690.00 +98.0%4.0%0.2 $2.10
5/15/202234,800 shares $115,118.40 -95.9%2.0%0.1 $3.31
4/30/2022856,400 shares $183,440.88 +7.5%N/A0.1 $0.21
4/15/2022796,400 shares $175,208.00 -84.4%N/A0.1 $0.22
3/31/20225,100,000 shares $1.43 million +1,933.5%38.7%0.5 $0.28
3/15/2022250,800 shares $42,134.40 +19.0%1.9%0 $0.17
2/28/2022210,800 shares $45,954.40 -56.7%1.6%0 $0.22
2/15/2022487,200 shares $89,157.60 -34.7%3.7%0.2 $0.18
1/31/2022746,200 shares $160,656.86 +294.6%5.7%0.3 $0.22
1/15/2022189,100 shares $101,735.80 -32.3%1.4%0.1 $0.54
12/31/2021279,200 shares $181,563.76 +50.6%2.3%0.5 $0.65
12/15/2021185,400 shares $119,564.46 -47.3%1.5%0.4 $0.64
11/30/2021351,800 shares $248,529.46 -31.1%2.9%0.7 $0.71
11/15/2021510,500 shares $433,925.00 -16.6%4.1%1.1 $0.85
10/29/2021612,000 shares $581,767.20 +107.0%5.0%1.3 $0.95
10/15/2021295,600 shares $275,114.92 -18.4%2.4%0.6 $0.93
9/30/2021362,300 shares $373,169.00 -24.4%2.9%0.2 $1.03
9/15/2021479,400 shares $498,576.00 -10.0%3.9%0.2 $1.04
8/31/2021532,900 shares $623,493.00 -3.0%4.3%0.2 $1.17
8/13/2021549,200 shares $648,056.00 -18.8%4.4%0.2 $1.18
7/30/2021675,900 shares $844,875.00 +38.9%5.1%0.3 $1.25
7/15/2021486,600 shares $729,900.00 -19.5%3.6%0.2 $1.50
6/30/2021604,700 shares $876,815.00 +19.2%4.5%2.5 $1.45
6/15/2021507,300 shares $715,293.00 -5.0%3.8%1.4 $1.41
5/28/2021533,900 shares $688,731.00 -3.2%4.0%0.9 $1.29
5/14/2021551,400 shares $634,110.00 +2.9%4.1%0.8 $1.15
4/30/2021536,100 shares $771,984.00 -19.7%4.0%0.5 $1.44
4/15/2021667,500 shares $987,900.00 +25.5%5.0%0.4 $1.48
3/31/2021531,700 shares $988,962.00 +21.1%4.0%0.2 $1.86
3/15/2021438,900 shares $877,800.00 +34.1%3.3%0.2 $2.00
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
2/26/2021327,300 shares $680,784.00 -77.3%2.4%0.1 $2.08
2/12/20211,440,000 shares $1.48 million +15.2%N/A0.6 $1.03
1/29/20211,250,000 shares $841,750.00 +15.7%N/A0.2 $0.67
1/15/20211,080,000 shares $683,532.00 +38.2%N/A0.2 $0.63
12/31/2020781,700 shares $269,686.50 +334.5%N/A0.2 $0.35
12/15/2020179,900 shares $55,265.28 +32.4%N/A0.1 $0.31
11/30/2020135,900 shares $40,076.91 +27.5%N/A0 $0.29
11/15/2020106,600 shares $27,982.50 -78.7%N/A0.1 $0.26
10/30/2020500,400 shares $146,367.00 +220.8%N/A0.2 $0.29
10/15/2020156,000 shares $42,057.60 +24.2%N/A0.1 $0.27
9/30/2020125,600 shares $30,746.88 -81.3%N/A0 $0.24
9/15/2020671,200 shares $171,558.72 +377.7%N/A0.2 $0.26
8/31/2020140,500 shares $42,178.10 -60.4%N/A0 $0.30
8/14/2020354,600 shares $131,131.08 +158.8%N/A0.1 $0.37
7/31/2020137,000 shares $54,334.20 +2.2%N/A0 $0.40
7/15/2020134,000 shares $58,263.20 -84.3%1.0%0 $0.43
6/30/2020853,600 shares $469,053.20 +723.9%6.3%0.1 $0.55
6/15/2020103,600 shares $46,640.72 -53.8%0.8%0 $0.45
5/29/2020224,200 shares $88,693.52 -73.5%1.7%0.1 $0.40
5/15/2020844,700 shares $372,259.29 +50.1%6.2%0.4 $0.44
4/30/2020562,800 shares $247,632.00 +25.1%4.2%0.3 $0.44
4/15/2020449,800 shares $193,414.00 -29.1%3.3%0.2 $0.43
3/31/2020634,600 shares $272,878.00 +21.3%4.7%0.3 $0.43
3/13/2020523,200 shares $204,048.00 +628.7%3.9%0.2 $0.39
2/28/202071,800 shares $44,516.00 +126.5%0.5%0 $0.62
2/14/202031,700 shares $27,896.00 -63.7%0.2%0 $0.88
1/31/202087,200 shares $78,480.00 -26.4%0.7%0.1 $0.90
1/15/2020118,500 shares $113,760.00 -15.4%0.9%0.2 $0.96
12/31/2019140,000 shares $124,600.00 +232.5%1.1%0.7 $0.89

SXTC Short Interest - Frequently Asked Questions

What is China SXT Pharmaceuticals' current short interest?

Short interest is the volume of China SXT Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 72,100 shares of SXTC short. 2.10% of China SXT Pharmaceuticals' shares are currently sold short. Learn More on China SXT Pharmaceuticals' current short interest.

What is a good short interest percentage for China SXT Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.10% of China SXT Pharmaceuticals' floating shares are currently sold short.

Is China SXT Pharmaceuticals' short interest increasing or decreasing?

China SXT Pharmaceuticals saw a increase in short interest in November. As of November 30th, there was short interest totaling 72,100 shares, an increase of 7.6% from the previous total of 67,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is China SXT Pharmaceuticals' float size?

China SXT Pharmaceuticals currently has issued a total of 4,062,000 shares. Some of China SXT Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. China SXT Pharmaceuticals currently has a public float of 3,430,000 shares.

How does China SXT Pharmaceuticals' short interest compare to its competitors?

2.10% of China SXT Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to China SXT Pharmaceuticals: CNS Pharmaceuticals, Inc. (3.60%), GT Biopharma, Inc. (0.57%), Syros Pharmaceuticals, Inc. (12.79%), Hoth Therapeutics, Inc. (6.70%), Purple Biotech Ltd (2.75%), IM Cannabis Corp. (10.73%), Elevai Labs, Inc. (1.89%), Aeterna Zentaris Inc. (0.18%), Biomerica, Inc. (8.50%), Bionomics Limited (2.27%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short China SXT Pharmaceuticals stock?

Short selling SXTC is an investing strategy that aims to generate trading profit from China SXT Pharmaceuticals as its price is falling. SXTC shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against China SXT Pharmaceuticals?

A short squeeze for China SXT Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SXTC, which in turn drives the price of the stock up even further.

How often is China SXT Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SXTC, twice per month. The most recent reporting period available is November, 30 2024.




This page (NASDAQ:SXTC) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners